Flex Ltd vs Eli Lilly And Co — how do they compare? Flex Ltd trades at $117.4 (market cap $42.40B), while Eli Lilly And Co trades at $1,164 (market cap $1.04T). The key difference: Eli Lilly And Co is far larger — about 24.5× Flex Ltd's market cap, and Eli Lilly And Co pays a 0.59% dividend while Flex Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flex Ltd for 3 Days and Eli Lilly And Co for 93 Days on average.
| FLEX | LLY | |
|---|---|---|
Market Cap | $42.40B | $1.04T |
Volume | 2,642,359 | 3,064,878 |
Sector | Technology | Health |
52-Week High | $162.07 | $1.28K |
52-Week Low | $54.51 | $799.57 |
Typical Hold Time | 3 Days | 93 Days |
Enterprise Value | $45.49B | $1.09T |
Dividend Yield | — | 0.59% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,188.72, up 2.7% today, reflecting strong momentum driven by robust earnings beats and bullish technical signals. The stock exhibits impressive fundamentals with 2025 revenue of $65.18B and net income of $20.64B, yielding a net margin of 31.66%. Recent news highlights promising pipeline developments in weight-loss drugs, including EloraTZP, which outperformed Zepbound in trials, reinforcing its competitive edge in the obesity and diabetes markets.
Outlook remains positive given analyst consensus of a $1,350 price target and 73% buy ratings, though high valuation multiples (P/E 39.26) and rising debt-to-asset ratios (42.78% in 2024) warrant caution. Key risks include regulatory hurdles and intensifying competition from rivals like Novo Nordisk, but Lilly's innovation pipeline and market leadership position it for sustained growth.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Flex provides design, engineering, manufacturing, supply chain, and logistics services for technology products. It serves industries including cloud, data centers, communications, automotive, healthcare, and industrials.
Read more on FLEX →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →